AstraZeneca

Biopharmaceuticals · Prescription Medicines

AstraZeneca is a global biopharmaceutical company that researches, develops and commercialises prescription medicines. Its portfolio spans oncology, rare diseases and biopharmaceuticals, including cardiovascular, renal and metabolic conditions, respiratory and immune-mediated diseases, and infectious disease. Its medicines serve patients through healthcare professionals and health systems worldwide.

The company earns most of its revenue from medicine sales and also records alliance revenue from partnered products and collaborations. It markets medicines across primary, specialty and rare-disease care while investing in clinical development and technologies such as biologics, cell therapy and precision medicine.